Expanded indications for transcatheter renal denervation.

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Nephrology

Background:

• Resistant hypertension is often linked to sympathetic nervous system (SNS) hyperactivity.
• Renal denervation (RDN) is a minimally invasive procedure targeting renal nerves to modulate SNS activity.
• Initial studies have established RDN's safety and efficacy for resistant hypertension.

Purpose of the Study:

• To review the established role of RDN in resistant hypertension.
• To explore the potential of RDN in managing other SNS-related conditions, particularly arrhythmias.
• To discuss the expanding indications and future research directions for RDN.

Main Methods:

• Systematic review of existing literature on RDN for resistant hypertension and related conditions.
• Analysis of studies investigating RDN's impact on arrhythmias, such as atrial fibrillation and ventricular arrhythmia.
• Discussion of preliminary findings and limitations in current research.

Main Results:

• RDN has demonstrated safety and effectiveness in treating resistant hypertension.
• Preliminary data suggest RDN may be beneficial for certain arrhythmias, including atrial fibrillation, when combined with other procedures.
• Further investigation is required to confirm RDN's efficacy in treating arrhythmias and other SNS-mediated conditions.

Conclusions:

• Renal denervation is a promising therapeutic option for resistant hypertension.
• The potential application of RDN extends to conditions associated with SNS hyperactivity, notably arrhythmias.
• Expanded indications for RDN warrant further research and clinical trials.